-
Články
- Časopisy
- Kurzy
- Témy
- Kongresy
- Videa
- Podcasty
How Much Can the USA Reduce Health Care Costs by Reducing Smoking?
In this Perspective, Wayne Hall and Chris Doran discuss Lightwood and Glantz’s findings and the implications for tobacco control programs in the US, which are currently poorly funded.
Vyšlo v časopise: How Much Can the USA Reduce Health Care Costs by Reducing Smoking?. PLoS Med 13(5): e32767. doi:10.1371/journal.pmed.1002021
Kategorie: Perspective
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.pmed.1002021Souhrn
In this Perspective, Wayne Hall and Chris Doran discuss Lightwood and Glantz’s findings and the implications for tobacco control programs in the US, which are currently poorly funded.
Zdroje
1. U.S. Department of Health and Human Services. The health consequences of smoking—50 years of progress: a report of the Surgeon General. Atlanta: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health; 2014. http://www.cdc.gov/tobacco/data_statistics/sgr/50th-anniversary/index.htm. Accessed February 29, 2016.
2. Xu X, Bishop EE, Kennedy SM, Simpson SA, Pechacek TF. Annual healthcare spending attributable to cigarette smoking: an update. Am J Prev Med. 2015;48(3):326–33. Epub 2014/12/17. doi: 10.1016/j.amepre.2014.10.012 25498551; PubMed Central PMCID: PMCPmc4603661.
3. Barendregt JJ, Bonneux L, van der Maas PJ. The health care costs of smoking. N Engl J Med. 1997;337(15):1052–7. doi: 10.1056/NEJM199710093371506 9321534.
4. Greenhalgh E, Bayly M, Winstanley M. 1.3 Prevalence of smoking—adults. In: Scollo M, Winstanley M, editors. Tobacco in Australia: facts and issues. Melbourne: Cancer Council Victoria; 2015. http://www.tobaccoinaustralia.org.au/chapter-1-prevalence/1-3-prevalence-of-smoking-adults/. Accessed March 15, 2016.
5. AIHW. Tobacco smoking (NDSHS 2013 key findings). Canberra: Australian Government; Australian Institute of Health and Welfare; 2016. Available from: http://www.aihw.gov.au/alcohol-and-other-drugs/ndshs/2013/tobacco/. Accessed February 29, 2016.
6. Vos T, Carter R, Barendregt J, Mihalopoulos C, Veerman J, Magnus A, et al. Assessing Cost-Effectiveness in Prevention (ACE–Prevention): final report. Brisbane, Melbourne: University of Queensland and Deakin University; 2010. https://public-health.uq.edu.au/filething/get/1836/ACE-Prevention_final_report.pdf. Accessed February 29, 2016.
7. Proctor R. Golden holocaust: origins of the cigarette catastrophe and the case for abolition. Berkeley: University of California Press; 2011.
8. Brandt A. The cigarette century: the rise, fall, and deadly persistence of the product that defined America. New York: Basic Books; 2007.
9. Centers for Disease Control and Prevention. Best practices for comprehensive tobacco control programs–2014. Atlanta: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health; 2014. http://www.cdc.gov/tobacco/stateandcommunity/best_practices/index.htm. Accessed February 29, 2016.
10. Health Florida. Florida Youth Tobacco Survey 2015. Tallahassee, FL: Florida Department of Health, Bureau of Epidemiology, Division of Disease Control and Health Protection; 2015. http://www.floridahealth.gov/statistics-and-data/survey-data/fl-youth-tobacco-survey/_documents/2015-state/index.html. Accessed March 15, 2016.
11. Campaign for Tobacco Free Kids. Broken promises to our children: a state by state look at the 1998 State Tobacco Settlement 17 years later. Washington, DC: Campaign for Tobacco Free Kids; 2015. http://www.tobaccofreekids.org/microsites/statereport2016/. Accessed February 29, 2016.
Štítky
Interné lekárstvo
Článok vyšiel v časopisePLOS Medicine
Najčítanejšie tento týždeň
2016 Číslo 5- Jak rozpoznat pacienty s familiární hypercholesterolémií ve své praxi
- Statinová intolerance
- Genetický podklad a screening familiární hypercholesterolémie
- Index SAMS-CI pro odhad souvislosti myopatií s léčbou statiny
- Statiny indukovaná myopatie: Jak na diferenciální diagnostiku?
-
Všetky články tohto čísla
- Epidemiology and Reporting Characteristics of Systematic Reviews of Biomedical Research: A Cross-Sectional Study
- Steroid-Based Therapy and Risk of Infectious Complications
- How Much Can the USA Reduce Health Care Costs by Reducing Smoking?
- Interpreting the Global Enteric Multicenter Study (GEMS) Findings on Sanitation, Hygiene, and Diarrhea
- Health Research and the World Humanitarian Summit—Not a Thousand Miles Apart
- A Public Health Paradox: The Women Most Vulnerable to Malaria Are the Least Protected
- Toward a Common Secure Future: Four Global Commissions in the Wake of Ebola
- The Clinical Challenge of Sepsis Identification and Monitoring
- All-Cause Mortality of Low Birthweight Infants in Infancy, Childhood, and Adolescence: Population Study of England and Wales
- Smoking Behavior and Healthcare Expenditure in the United States, 1992–2009: Panel Data Estimates
- Estimating the Risk of Chronic Pain: Development and Validation of a Prognostic Model (PICKUP) for Patients with Acute Low Back Pain
- Initiating Antiretroviral Therapy for HIV at a Patient’s First Clinic Visit: The RapIT Randomized Controlled Trial
- Prioritizing Surgical Care on National Health Agendas: A Qualitative Case Study of Papua New Guinea, Uganda, and Sierra Leone
- Effectiveness of and Financial Returns to Voluntary Medical Male Circumcision for HIV Prevention in South Africa: An Incremental Cost-Effectiveness Analysis
- Risk of Advanced Neoplasia in First-Degree Relatives with Colorectal Cancer: A Large Multicenter Cross-Sectional Study
- Common Infections in Patients Prescribed Systemic Glucocorticoids in Primary Care: A Population-Based Cohort Study
- Sanitation and Hygiene-Specific Risk Factors for Moderate-to-Severe Diarrhea in Young Children in the Global Enteric Multicenter Study, 2007–2011: Case-Control Study
- A Revolution in Treatment for Hepatitis C Infection: Mitigating the Budgetary Impact
- Nondisclosure of Financial Interest in Clinical Practice Guideline Development: An Intractable Problem?
- Financial Relationships between Organizations That Produce Clinical Practice Guidelines and the Biomedical Industry: A Cross-Sectional Study
- Prices, Costs, and Affordability of New Medicines for Hepatitis C in 30 Countries: An Economic Analysis
- PLOS Medicine
- Archív čísel
- Aktuálne číslo
- Informácie o časopise
Najčítanejšie v tomto čísle- Estimating the Risk of Chronic Pain: Development and Validation of a Prognostic Model (PICKUP) for Patients with Acute Low Back Pain
- Prioritizing Surgical Care on National Health Agendas: A Qualitative Case Study of Papua New Guinea, Uganda, and Sierra Leone
- A Revolution in Treatment for Hepatitis C Infection: Mitigating the Budgetary Impact
- Toward a Common Secure Future: Four Global Commissions in the Wake of Ebola
Prihlásenie#ADS_BOTTOM_SCRIPTS#Zabudnuté hesloZadajte e-mailovú adresu, s ktorou ste vytvárali účet. Budú Vám na ňu zasielané informácie k nastaveniu nového hesla.
- Časopisy